Page last updated: 2024-08-17

prednisone and metformin

prednisone has been researched along with metformin in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.35)18.7374
1990's0 (0.00)18.2507
2000's7 (30.43)29.6817
2010's9 (39.13)24.3611
2020's6 (26.09)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Amar, U; Bouaziz, M; Levy, JM; Segura, N; Stoll, C; Thierry, R1
Hampl, R; Hill, M; Hoza, J; Kot'átková, A; Nĕmcová, D; Stárka, L; Vondra, K; Vrbíková, J; Zamrazil, V1
Bendlová, B; Bílek, R; Hampl, R; Hill, M; Hoza, J; Kot'átková, A; Nĕmcová, D; Stárka, L; Vondra, K; Vrbíková, J; Zamrazil, V1
Ha, T; Koo, YX; Lim, ST; Ong, WS; Quek, R; Tai, DW; Tan, DS; Tan, IB; Tao, M1
Bally, M; Christ-Crain, M; Korbonits, M; Meyer, S; Müller, B; Nigro, N; Pernicova, I; Schuetz, P; Seelig, E; Timper, K1
Geller, S; Kremer, N; Sprecher, E; Zeeli, T1
Abdel-Rahman, O1
Guantai, EM; Nyamu, DG; Ochola, LA; Weru, IW1
Adel, MM; Fogelfeld, L; Guerra, Y; Shah, M; Tahsin, B1
Besson, D; Borchiellini, D; Bost, F; Cheli, S; Deville, JL; El Kouri, C; Ferrero, JM; Guillot, A; Hilgers, W; Hoch, B; Milano, G; Paoli, JB; Priou, F; Pujalte Martin, M; Schiappa, R; Tanti, JF; Thamphya, B1
Fernandez, F; Landis, D; Nugent, K; Sutter, A1
Armstrong, AJ; Carles, J; Chi, KN; de Bono, J; De Porre, P; Fizazi, K; Gillessen, S; Hu, P; Jones, RJ; Joshua, AM; Logothetis, CJ; Rathkopf, D; Ryan, CJ; Saad, F; Scher, HI; Smith, MR; Sternberg, CN; Tran, N; Wilson, BE1
Aprikian, AG; Dragomir, A; Kassouf, W; O'Flaherty, A; Tanguay, S; Wissing, MD1

Reviews

2 review(s) available for prednisone and metformin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
The effect of metformin on glucose metabolism in patients receiving glucocorticoids.
    The American journal of the medical sciences, 2022, Volume: 364, Issue:4

    Topics: Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids; Glucocorticoids; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Prednisone

2022

Trials

6 trial(s) available for prednisone and metformin

ArticleYear
Metformin prevents metabolic side effects during systemic glucocorticoid treatment.
    European journal of endocrinology, 2017, Volume: 176, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Blood Glucose; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Humans; Hypoglycemic Agents; Male; Metformin; Methylprednisolone; Middle Aged; Prednisolone; Prednisone; Treatment Outcome

2017
Impact of Diabetes on the Outcomes of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel: A Pooled Analysis of Three Phase III Studies.
    Clinical genitourinary cancer, 2019, Volume: 17, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Diabetes Mellitus; Docetaxel; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Meta-Analysis as Topic; Metformin; Prednisone; Prognosis; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Rate

2019
Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:4

    Topics: Adult; Aged; Blood Glucose; Fasting; Female; Hematologic Neoplasms; Humans; Hyperglycemia; Hypoglycemic Agents; Kenya; Male; Metformin; Middle Aged; Postprandial Period; Prednisone; Prospective Studies; Young Adult

2020
Effect of short-term prednisone on beta-cell function in subjects with type 2 diabetes mellitus and healthy subjects.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Prednisone; Young Adult

2020
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
    Clinical genitourinary cancer, 2021, Volume: 19, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Humans; Male; Metformin; Prednisone; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Retrospective Studies; Treatment Outcome

2021
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 170

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Castration; Disease-Free Survival; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metformin; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome

2022

Other Studies

15 other study(ies) available for prednisone and metformin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
[Exogenous steroid diabetes in a leukemic boy. Study of insulin and GH blood levels].
    Archives francaises de pediatrie, 1973, Volume: 30, Issue:10

    Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucose Tolerance Test; Growth Hormone; Humans; Hypoglycemia; Injections, Intravenous; Insulin; Leukemia, Lymphoid; Lipids; Male; Metformin; Prednisone; Time Factors

1973
[Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Casopis lekaru ceskych, 2002, Feb-15, Volume: 141, Issue:3

    Topics: Adolescent; Adult; Androgens; Connective Tissue Diseases; Female; Glucocorticoids; Glucose; Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Metformin; Prednisone; Sex Hormone-Binding Globulin

2002
[Metformin has a positive effect on disorders of carbohydrate metabolism in long-term care with low doses of prednisone].
    Casopis lekaru ceskych, 2002, Apr-26, Volume: 141, Issue:8

    Topics: Adolescent; Adult; Female; Glucocorticoids; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Prednisone

2002
Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Metformin; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine; Young Adult

2011
Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
    International journal of dermatology, 2017, Volume: 56, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Head; Hospitalization; Humans; Hypertension; Hypoglycemic Agents; Immunosuppressive Agents; Male; Metformin; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prednisone; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tetracycline; Treatment Failure

2017
Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada.
    BMC urology, 2023, Jul-14, Volume: 23, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Canada; Cystectomy; Disease-Free Survival; Humans; Metformin; Prednisone; Quebec; Retrospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms

2023